Skip to main content
Caplight Logo









Vortex Biosciences

Vortex Biosciences

Private
ManchesterHealthcare & Life Scienceshttps://vortexctc.ai/

Last Round

VC Round

Jun 22, 2023

Total Funding Raised

$2.42M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vortex Biosciences is a biotechnology company that develops and provides a liquid biopsy platform designed for the automated isolation of circulating tumor cells from whole blood for cancer diagnostics and research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

liquid biopsycirculating tumor cellsCTCsCTC isolationmicrofluidic technologylabel-free cell separationoncology researchmicrofluidic cartridgessample preparationnon-invasive diagnosticsbiotech equipmentlab-on-a-chipcell sortingpersonalized medicinerazor and blade modelResearch Use OnlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vortex Biosciences Comparables

Compare Vortex Biosciences with similar companies based on industry and business-model similarity.

Vortex Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cytotrait
90%
Cell Microsystems
84%
CelLBxHealth plc
83%

Vortex Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 22, 2023
VC RoundAug 16, 2022
DebtAug 16, 2022
VC RoundApr 25, 2019

Vortex Biosciences Investors

Notable investors and investment history

Vortex Biosciences investors
InvestorRounds
EMV CapitalDebt, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 63% MoM.

  • May 18, 2026

    Monthly visitors grew 121% MoM, from 217 to 479.

Vortex Biosciences Filings

Explore SEC and related filing metadata, where available.

Vortex Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vortex Biosciences's valuation, stock price, and market status.

Is Vortex Biosciences a public or private company?

Vortex Biosciences is a private company.

What is the current stock price of Vortex Biosciences?

Vortex Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Vortex Biosciences worth (valuation)?

Valuation information for Vortex Biosciences is not publicly available.

Can I buy Vortex Biosciences stock?

Vortex Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vortex Biosciences's last funding round?

Vortex Biosciences's most recent funding round was VC Round on June 22, 2023.

Who are the main investors in Vortex Biosciences?

Key investors in Vortex Biosciences include EMV Capital.

Will Vortex Biosciences IPO soon?

No public IPO plans have been announced for Vortex Biosciences.

How can I track Vortex Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vortex Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersManchester
Employee Range4
Year Founded2012
Last FundingJun 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?